MKI67 and nasopharyngeal carcinoma: In this study, the high and low-medium Ki67 expression groups showed no statistically significant difference in LRFS of NPC (P = 0.547), and local recurrence risk did not increase significantly (HR = 1.266, 95% CI 0.587–2.728, P = 0.547).